Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
31 May 2023
General Assembly, General meetings

Auditors’ report on 2022 consolidated financial statements in accordance with IFRS Open in new window

31 May 2023
General Assembly, General meetings

Auditors’ report on 2021 financial statements in accordance with French GAAPs Open in new window

31 May 2023
General Assembly, General meetings

Shares and voting rights statement – 2023 General Meeting Open in new window

31 May 2023
General Assembly, General meetings

Proxy card – 2023 General Meeting Open in new window

31 May 2023
General Assembly, General meetings

Preliminary notice of the 2022 General Meeting Open in new window

10 May 2023
Financial statements and reports

2022 Universal Registration Document Open in new window

25 April 2023
Corporate presentations

CORPORATE PRESENTATION-APRIL 2023 Open in new window

13 September 2022
Corporate presentations

CORPORATE PRESENTATION – SEPTEMBER 2022 Open in new window

02 September 2022
Regulated information

Statutes of the Company Open in new window

28 July 2022
Financial statements and reports

2022 Half-Year Financial Report Open in new window

  • View previous 9 articles
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 23
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page